BRS1-FM4-PM7 - GABA–Glutamate Neurotransmission Balance
(Excitation–Inhibition Balance for Neural Stability)
1. Mission & Overview
Mission
Keep excitatory glutamate and inhibitory GABA signalling matched so neural networks operate with stability.
Overview
Represents the net balance between glutamatergic excitation and GABAergic inhibition (the brain's principal excitatory–inhibitory neurotransmitter pair) rather than either arm's synthesis or clearance individually, which sibling mechanisms cover. When these two signalling arms are well matched, neural circuits maintain stable excitability appropriate to task demand; when the balance shifts toward excess excitation, attention, emotional control, and sensory processing all become more vulnerable to overload.
- Represents net excitatory–inhibitory balance rather than either arm alone.
- Supports stable network excitability appropriate to task demand.
- Sets the regulatory context for sibling synthesis and clearance mechanisms.
2. Primary Biological Effects
↑ excitation–inhibition balance; ↑ inhibitory tone support
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: High
- Rationale: Excitatory–inhibitory balance between glutamate and GABA is a core biological determinant of attentional stability in ADHD — supported by reduced GABA biomarker studies in ADHD cohorts (Edden et al., 2012; Puts et al., 2020) and glutamate– attention associations (Maltezos et al., 2014). This PM integrates E/I tone; synthesis and clearance are handled on PM8–PM9.
- Key References:
- Edden et al. (2012) — Human Mechanistic
- Puts et al. (2020) — Human Mechanistic
- Maltezos et al. (2014) — Human Mechanistic
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Medium
- Rationale: Matched GABAergic–glutamatergic excitation–inhibition balance is a major contributory determinant of emotional control and reactivity; substantial E/I imbalance would be expected to impair Emotional Regulation as a direct biological consequence. Edden et al. (2012) and Puts et al. (2020) report reduced GABA in ADHD cohorts; Evidence Confidence is low because biomarkers do not measure emotional-regulation scales directly on this row.
- Key References:
- Evidence Confidence: Low
- Biology → Phenome Confidence: Low–Medium
- Rationale: Excitation–inhibition balance modulates inhibitory control under arousal load; matched E/I tone is a contributory determinant of Stress Reactivity when excitatory drive exceeds inhibitory capacity. Mamiya et al. (2021) establishes E/I network framing; Evidence Confidence is low because attached refs do not directly measure stress-reactivity outcomes on this PM.
- Key References:
- Evidence Confidence: Low
4. Levers
Intervention Profile
Intervention Dominance: Diet-Supported
- Magnesium ← leafy greens
- Magnesium + zinc ← pumpkin seeds
- protein-rich foods → precursor context.
- Vitamin B6 ← poultry, fish, chickpeas
- Magnesium ← leafy greens
- zinc
-
Complete essential amino-acid supply ← eggs, fish, dairy, meat, soy, legumes, grains
-
Tryptophan ← eggs, dairy, fish, poultry, soy, pumpkin seeds
-
Phenylalanine and tyrosine ← dairy, meat, fish, eggs, soy, legumes, nuts, seeds
1. Food Preparation & Delivery ONLY
- Use complementary protein pairing and distributed protein across meals to support amino-acid availability — see Eggs — Synergies, Lentils — Synergies.
- Soak or sprout phytate-rich seeds and legumes to improve plant zinc and mineral bioavailability.
- Best prepared with gentle cooking to preserve omega-3s and prevent oxidation — see Salmon — Preparation.
- Prefer gentle or moist-heat cooking methods (baking, steaming, stewing) to help preserve EPA/DHA… — see Mackerel — Preparation.
- Meal timing and circadian-aligned eating may influence precursor transport and neurotransmitter bias.
- Physical activity and stress recovery practices may modulate catecholamine and autonomic context where listed in interventions.
5. Mechanistic Basis
Summary
BRS1-FM4-PM7 anchors excitatory–inhibitory balance between GABAergic and glutamatergic signalling relevant to attention, reactivity, and inhibitory control. Dietary patterns supporting GABA synthesis, glutamate handling, and cofactor sufficiency (B6, magnesium, zinc) provide the substrate and biochemical context for BRS1(FM4).
(Excitatory–inhibitory balance as a network property)
Attention and behavioural control depend on the relative balance of excitatory glutamatergic drive and inhibitory GABAergic tone. Shifts in this balance have been implicated in variability in inhibitory control and neurochemical profiles relevant to attention-related conditions → [Edden et al., 2012]
(Dietary support across the E/I cluster)
BRS1-FM4-PM7 integrates meal-level support from protein context, magnesium- and zinc-containing foods, and B6 adequacy (section 7.2), coordinating with BRS1-FM4-PM8 and BRS1-FM4-PM9 rather than replacing their specific mechanisms → [Puts et al., 2020]
(Glycaemic and stress cross-links)
Glycaemic instability and stress load (section 5.3) can indirectly affect arousal and inhibitory control, but the primary biological frame for this PM remains E/I neurotransmission balance.
(Key constraint)
BRS1-FM1-PM1 provides meal-level amino-acid substrate context for glutamate precursor pools.
Together, BRS1-FM4-PM7 defines the integrative FM-level balance point for inhibitory and excitatory signalling supported by sibling PMs in the same cluster.
5.1 Evidence Highlights
Introduction/Summary
Excitatory–inhibitory balance biology is well established. The studies below highlight network-level E/I framing that refines how this integrative PM is interpreted — not condition-specific biomarker claims.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Neural excitation and inhibition balance operates as a coordinated network property across inhibitory and excitatory signalling systems rather than as isolated transmitter effects [Mamiya et al., 2021].
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS3-FM1-PM1 — NF-kB Signalling Regulation — Inflammatory Tone Regulation
- BRS4-FM1-PM1 — Electron Transport Chain Function — Mitochondrial Bioenergetic Support
- BRS6-FM1-PM1 — Glucose Appearance Kinetics — Glycaemic Stability
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS1-FM4-PM8 - GABA Synthesis Capacity
- BRS1-FM4-PM9 - Glutamate Clearance & Recycling
- BRS1-FM4-PM10 - Excitotoxicity Modulation
7. Scoreable Inputs & Modulation Signals
This PM is scoreable through food-state and nutrient signals relevant to gaba–glutamate neurotransmission balance.
| Input Category | Example Inputs | PM6 Relevance |
|---|---|---|
| Functional Property Potentials | complete_protein_context; lnna_transport_context; choline_rich_food_matrix | May influence meal-level mechanism support. |
| Realised Functional States | balanced_protein_meal; slow_carbohydrate_pairing | Represent recipe-level realised states. |
| Preparation Transformations | complementary_protein_pairing; minimally_processed_sources | Modify bioavailability and meal-matrix effects. |
8. References
- Edden et al. (2012) — Reduced GABA Concentration in Attention-Deficit/Hyperactivity Disorder
- Puts et al. (2020) — Reduced Striatal GABA in Unmedicated Children with ADHD At 7T
- Maltezos et al. (2014) — Glutamate/Glutamine and Neuronal Integrity in Adults with ADHD
- Mamiya et al. (2021) — Case for Neural Excitation and Inhibition